Eurepa-V 1/0.2 Tablet

By Eurepa-V

Rx

10 Tablet in a Strip

Composition icon

Composition

Repaglinide(1mg) + Voglibose(0.2mg)

Manufacturer - Torrent Pharmaceuticals Ltd icon

Manufacturer - Torrent Pharmaceuticals Ltd

Off. Ashram Road, Ahmedabad - 380 009., Gujarat, India

Expires on or after icon

Expires on or after

October, 2026

About Eurepa-V 1/0.2 Tablet

Eurepa-V 1/0.2 Tablet is a medication specifically designed for managing type 2 diabetes mellitus. This tablet is a combination of two medicines that work together to regulate high blood sugar levels in the body after eating. It is typically prescribed when other similar medications, in conjunction with dietary restrictions, are unable to effectively control the elevated blood sugar levels.

It is important to take Eurepa-V 1/0.2 Tablet right after your meals, and the appropriate dosage should be determined by your doctor. It is crucial not to discontinue the medication without consulting your healthcare provider, as doing so may lead to a spike in blood sugar levels, potentially resulting in serious complications such as kidney damage and vision problems.

In the event that you miss a dose, it is advised not to take the missed dose between meals. Instead, wait until your next meal and take it as usual just after eating. Avoid doubling the dose to compensate for the missed one. Remember, Eurepa-V 1/0.2 Tablet is just one component of a comprehensive treatment plan that should also include a balanced diet, regular physical activity, and weight management as directed by your doctor.

While this medication is generally well-tolerated, some common side effects may include flatulence, diarrhea, stomach pain, low blood sugar levels, and skin rashes. These side effects are often temporary and tend to resolve on their own. However, if they persist or worsen, it is advisable to seek guidance from your doctor. It is essential to monitor your blood sugar levels regularly while using this medication.

Before starting Eurepa-V 1/0.2 Tablet, inform your healthcare provider if you have any existing kidney or liver issues, urinary tract infections, or if you are taking water pills. Pregnant or lactating women should also seek medical advice before initiating this medication. Additionally, it is recommended to moderate alcohol consumption while on this treatment, as excessive intake may heighten the risk of experiencing adverse effects.


Benefits

Eurepa-V 1/0.2 Tablet is a valuable medication used in the treatment of Type 2 diabetes mellitus. It plays a crucial role in controlling high levels of blood glucose, assisting in the removal of excess glucose from the body through urine. By slowing down the breakdown of food in the intestine to simple glucose, it effectively prevents a rapid increase in blood sugar levels following meals. Managing blood glucose levels is vital in diabetes care, as it significantly reduces the risk of serious complications associated with the condition, such as kidney damage, eye issues, nerve problems, and even limb loss.

Moreover, Eurepa-V 1/0.2 Tablet has been proven to lower the risk of cardiovascular disease-related mortality in individuals with Type 2 diabetes who already suffer from cardiovascular issues. Consistent use of this medication, alongside a balanced diet and regular exercise, is instrumental in helping individuals lead a normal and healthy life. It is essential to adhere to the prescribed regimen, as the drug works to safeguard the individual's future health and well-being. By incorporating Eurepa-V 1/0.2 Tablet into your daily routine as directed by your healthcare provider, you are taking proactive steps towards maintaining optimal health and minimizing the complications associated with diabetes and cardiovascular diseases.


How to use the Eurepa-V 1/0.2 Tablet

To use Eurepa-V 1/0.2 Tablet, follow your doctor's instructions on the dose and duration. It is important to take the tablet as a whole with food. Do not chew, crush, or break the tablet before swallowing. Taking Eurepa-V 1/0.2 Tablet with food can help improve its effectiveness and reduce the chances of any potential side effects. If you have any questions or concerns about how to use this medication, consult your doctor or pharmacist for guidance.


Uses of Eurepa-V 1/0.2 Tablet

Eurepa-V 1/0.2 Tablet is commonly used for the treatment of Type 2 diabetes mellitus. It is prescribed to help manage blood sugar levels in patients with this condition. The tablet is formulated to be effective in controlling and regulating glucose levels in the body, which is essential for individuals living with Type 2 diabetes mellitus. It is important to follow the dosage instructions provided by the healthcare provider to maximize the benefits of Eurepa-V 1/0.2 Tablet in managing this chronic condition.


What conditions Eurepa-V 1/0.2 Tablet treats?

Eurepa-V 1/0.2 Tablet is a medication used for treating type 2 diabetes mellitus. It helps to control high blood sugar levels after meals when other treatments and diet adjustments are insufficient. By managing blood sugar levels, this medication reduces the risk of serious complications such as kidney damage, eye problems, nerve issues, and cardiovascular diseases. It is important to take Eurepa-V 1/0.2 Tablet regularly as prescribed, along with a healthy diet and exercise, to maintain a normal and healthy life. Inform your doctor about any existing health conditions before starting this medication.


Should you consult a doctor?

It is important to seek medical attention when taking Eurepa-V 1/0.2 Tablet if you experience persistent side effects such as abdominal pain, diarrhea, flatulence, headache, or hypoglycemia (low blood sugar level). These side effects can sometimes indicate a more serious issue and should not be ignored. Additionally, if you miss a dose, do not try to make up for it by taking a double dose. Consult your doctor if you are unsure about what to do. It is crucial to monitor your blood sugar levels regularly while on this medication and inform your doctor if you have any kidney or liver problems, urinary tract infection, or if you are pregnant or breastfeeding. Remember, Eurepa-V 1/0.2 Tablet is just one part of your treatment plan, which should also include a healthy diet, regular exercise, and weight reduction as advised by your doctor.


Side effects of Eurepa-V 1/0.2 Tablet

When taking Eurepa-V 1/0.2 Tablet, some patients may experience side effects. Most side effects are temporary and diminish as your body gets used to the medication. However, it is important to consult your doctor if any side effects persist or cause concern. Common side effects of Eurepa-V 1/0.2 Tablet may include hypoglycemia, which is a low blood glucose level that can lead to symptoms such as weakness or sweating. Other side effects may include abdominal pain, diarrhea, flatulence, and headache. If you experience any of these side effects, it is advisable to seek medical advice to ensure your well-being while taking this medication.


Safety advice

scroll

liver

When using Eurepa-V 1/0.2 Tablet, it is important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when taking Eurepa-V 1/0.2 Tablet. It is advised to consult your doctor before using this medication to ensure proper guidance and monitoring for liver-related concerns.

scroll

kidney

Eurepa-V 1/0.2 Tablet should be used carefully in individuals with serious kidney problems. Adjusting the dosage of Eurepa-V 1/0.2 Tablet might be necessary. Seek advice from your healthcare provider.

scroll

alcohol

It is not safe to drink alcohol while taking Eurepa-V 1/0.2 Tablet.

scroll

driving

While taking Eurepa-V 1/0.2 Tablet, be cautious when driving. Low or high blood sugar levels can affect your ability to drive. If you experience these symptoms, avoid driving.

scroll

pregnancy

Eurepa-V 1/0.2 Tablet should be used with caution during pregnancy as it may not be safe. Limited human studies suggest potential harm to the baby. Your doctor will assess the benefits and risks before prescribing. Consult your doctor before taking Eurepa-V 1/0.2 Tablet during pregnancy.

scroll

breastfeeding

Eurepa-V 1/0.2 Tablet may not be safe to use while breastfeeding. Limited data indicates potential transfer of the drug to breastmilk, posing a risk to the baby.


Consumption warning before consuming Eurepa-V 1/0.2 Tablet

Before consuming Eurepa-V 1/0.2 Tablet, it is important to note several key points. This medication is used to manage high blood sugar levels in individuals with type 2 diabetes mellitus when other treatments and a restricted diet are insufficient. It should always be taken immediately after meals, with the dosage determined by your doctor. Stopping the medication without consulting your doctor can lead to increased blood sugar levels, possibly resulting in severe complications like kidney damage and vision problems.

In case a dose is missed, do not take it between meals; instead, wait until your next meal to resume regular dosing. Avoid doubling up on doses to compensate for a missed one. It is crucial to incorporate this medication into a broader treatment program that involves a balanced diet, regular exercise, and weight management as prescribed by your healthcare provider.

Common side effects may include flatulence, diarrhea, stomach discomfort, low blood sugar levels, and skin rashes, but these effects typically resolve on their own. If they persist, it is advisable to seek medical advice. Ensure to monitor your blood sugar levels regularly while on this medication. Prior to starting treatment, inform your doctor about any existing kidney or liver issues, urinary tract infections, or the use of diuretics. Pregnant or breastfeeding women should consult with their healthcare provider before taking this medication and should steer clear of excessive alcohol consumption, which can potentially heighten the risk of side effects.


What if you forgot to take Eurepa-V 1/0.2 Tablet?

If you forgot to take your Eurepa-V 1/0.2 Tablet, take it as soon as you remember. But if it's almost time for your next dose, just skip the missed one and stick to your usual dosing schedule. It's important not to take a double dose to make up for the missed one. Just resume your medication as prescribed.


Related lab tests

For patients taking Eurepa-V 1/0.2 Tablet, there are several related lab tests that may be recommended to monitor their health. These tests include Glucose - Fasting Blood, Glucose - Postprandial Blood, and Glycosylated Hemoglobin. These tests are vital in assessing blood sugar levels before and after meals, as well as over a longer period of time. Glucose - Fasting Blood test measures the amount of sugar in the blood after a period of fasting, providing insight into how the body is processing glucose. The Glucose - Postprandial Blood test, on the other hand, measures blood sugar levels after a meal, indicating how the body responds to food intake. Lastly, the Glycosylated Hemoglobin test reflects average blood sugar levels over the past few months, offering a comprehensive view of long-term glucose control. These tests are crucial in managing diabetes and ensuring optimal health outcomes for patients on Eurepa-V 1/0.2 Tablet.


Additional Information

Habit FormingNo
Chemical Class-
Therapeutic ClassANTI DIABETIC
Action Class-

FAQs


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

199

Inclusive of all taxes

Content verified by

chevron-right

Dr. Abdullah Khan

MBBS - General Medicine

Last update on 01-Oct-2024